Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -8.39 |
peg ratio | 0.16 |
price to book ratio | 15.28 |
price to sales ratio | 6.49 |
enterprise value multiple | -9.74 |
price fair value | 15.28 |
profitability ratios | |
---|---|
gross profit margin | 89.44% |
operating profit margin | -65.09% |
pretax profit margin | -73.83% |
net profit margin | -76.93% |
return on assets | -45.36% |
return on equity | 26.28% |
return on capital employed | -61.91% |
liquidity ratio | |
---|---|
current ratio | 2.48 |
quick ratio | 2.12 |
cash ratio | 0.40 |
efficiency ratio | |
---|---|
days of inventory outstanding | 795.05 |
operating cycle | 878.53 |
days of payables outstanding | 306.31 |
cash conversion cycle | 572.22 |
receivables turnover | 4.37 |
payables turnover | 1.19 |
inventory turnover | 0.46 |
debt and solvency ratios | |
---|---|
debt ratio | 0.45 |
debt equity ratio | 1.80 |
long term debt to capitalization | 0.57 |
total debt to capitalization | 0.64 |
interest coverage | -4.24 |
cash flow to debt ratio | -0.85 |
cash flow ratios | |
---|---|
free cash flow per share | -0.72 |
cash per share | 1.16 |
operating cash flow per share | -0.72 |
free cash flow operating cash flow ratio | 1.00 |
cash flow coverage ratios | -0.85 |
short term coverage ratios | -3.29 |
capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
G1 Therapeutics, Inc. (GTHX) published its most recent earnings results on 08-08-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. G1 Therapeutics, Inc. (NASDAQ:GTHX)'s trailing twelve months ROE is 26.28%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. G1 Therapeutics, Inc. (GTHX) currently has a ROA of -45.36%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
GTHX reported a profit margin of -76.93% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.48 in the most recent quarter. The quick ratio stood at 2.12, with a Debt/Eq ratio of 1.80.